Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI

CP. Spielvogel, J. Ning, K. Kluge, D. Haberl, G. Wasinger, J. Yu, H. Einspieler, L. Papp, B. Grubmüller, SF. Shariat, PAT. Baltzer, P. Clauser, M. Hartenbach, L. Kenner, M. Hacker, AR. Haug, S. Rasul

. 2024 ; 15 (1) : 299. [pub] 20241212

Status neindexováno Jazyk angličtina Země Německo

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25001956

OBJECTIVES: Radical prostatectomy (RP) is a common intervention in patients with localized prostate cancer (PCa), with nerve-sparing RP recommended to reduce adverse effects on patient quality of life. Accurate pre-operative detection of extraprostatic extension (EPE) remains challenging, often leading to the application of suboptimal treatment. The aim of this study was to enhance pre-operative EPE detection through multimodal data integration using explainable machine learning (ML). METHODS: Patients with newly diagnosed PCa who underwent [68Ga]Ga-PSMA-11 PET/MRI and subsequent RP were recruited retrospectively from two time ranges for training, cross-validation, and independent validation. The presence of EPE was measured from post-surgical histopathology and predicted using ML and pre-operative parameters, including PET/MRI-derived features, blood-based markers, histology-derived parameters, and demographic parameters. ML models were subsequently compared with conventional PET/MRI-based image readings. RESULTS: The study involved 107 patients, 59 (55%) of whom were affected by EPE according to postoperative findings for the initial training and cross-validation. The ML models demonstrated superior diagnostic performance over conventional PET/MRI image readings, with the explainable boosting machine model achieving an AUC of 0.88 (95% CI 0.87-0.89) during cross-validation and an AUC of 0.88 (95% CI 0.75-0.97) during independent validation. The ML approach integrating invasive features demonstrated better predictive capabilities for EPE compared to visual clinical read-outs (Cross-validation AUC 0.88 versus 0.71, p = 0.02). CONCLUSION: ML based on routinely acquired clinical data can significantly improve the pre-operative detection of EPE in PCa patients, potentially enabling more accurate clinical staging and decision-making, thereby improving patient outcomes. CRITICAL RELEVANCE STATEMENT: This study demonstrates that integrating multimodal data with machine learning significantly improves the pre-operative detection of extraprostatic extension in prostate cancer patients, outperforming conventional imaging methods and potentially leading to more accurate clinical staging and better treatment decisions. KEY POINTS: Extraprostatic extension is an important indicator guiding treatment approaches. Current assessment of extraprostatic extension is difficult and lacks accuracy. Machine learning improves detection of extraprostatic extension using PSMA-PET/MRI and histopathology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25001956
003      
CZ-PrNML
005      
20250123102001.0
007      
ta
008      
250117s2024 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13244-024-01876-5 $2 doi
035    __
$a (PubMed)39666257
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Spielvogel, Clemens P $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
245    10
$a Preoperative detection of extraprostatic tumor extension in patients with primary prostate cancer utilizing [68Ga]Ga-PSMA-11 PET/MRI / $c CP. Spielvogel, J. Ning, K. Kluge, D. Haberl, G. Wasinger, J. Yu, H. Einspieler, L. Papp, B. Grubmüller, SF. Shariat, PAT. Baltzer, P. Clauser, M. Hartenbach, L. Kenner, M. Hacker, AR. Haug, S. Rasul
520    9_
$a OBJECTIVES: Radical prostatectomy (RP) is a common intervention in patients with localized prostate cancer (PCa), with nerve-sparing RP recommended to reduce adverse effects on patient quality of life. Accurate pre-operative detection of extraprostatic extension (EPE) remains challenging, often leading to the application of suboptimal treatment. The aim of this study was to enhance pre-operative EPE detection through multimodal data integration using explainable machine learning (ML). METHODS: Patients with newly diagnosed PCa who underwent [68Ga]Ga-PSMA-11 PET/MRI and subsequent RP were recruited retrospectively from two time ranges for training, cross-validation, and independent validation. The presence of EPE was measured from post-surgical histopathology and predicted using ML and pre-operative parameters, including PET/MRI-derived features, blood-based markers, histology-derived parameters, and demographic parameters. ML models were subsequently compared with conventional PET/MRI-based image readings. RESULTS: The study involved 107 patients, 59 (55%) of whom were affected by EPE according to postoperative findings for the initial training and cross-validation. The ML models demonstrated superior diagnostic performance over conventional PET/MRI image readings, with the explainable boosting machine model achieving an AUC of 0.88 (95% CI 0.87-0.89) during cross-validation and an AUC of 0.88 (95% CI 0.75-0.97) during independent validation. The ML approach integrating invasive features demonstrated better predictive capabilities for EPE compared to visual clinical read-outs (Cross-validation AUC 0.88 versus 0.71, p = 0.02). CONCLUSION: ML based on routinely acquired clinical data can significantly improve the pre-operative detection of EPE in PCa patients, potentially enabling more accurate clinical staging and decision-making, thereby improving patient outcomes. CRITICAL RELEVANCE STATEMENT: This study demonstrates that integrating multimodal data with machine learning significantly improves the pre-operative detection of extraprostatic extension in prostate cancer patients, outperforming conventional imaging methods and potentially leading to more accurate clinical staging and better treatment decisions. KEY POINTS: Extraprostatic extension is an important indicator guiding treatment approaches. Current assessment of extraprostatic extension is difficult and lacks accuracy. Machine learning improves detection of extraprostatic extension using PSMA-PET/MRI and histopathology.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ning, Jing $u Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria $u Department of Pathology, Medical University of Vienna, Vienna, Austria
700    1_
$a Kluge, Kilian $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria $u Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria
700    1_
$a Haberl, David $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
700    1_
$a Wasinger, Gabriel $u Department of Pathology, Medical University of Vienna, Vienna, Austria
700    1_
$a Yu, Josef $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
700    1_
$a Einspieler, Holger $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
700    1_
$a Papp, Laszlo $u Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
700    1_
$a Grubmüller, Bernhard $u Department of Urology and Andrology, University Hospital Krems, Krems, Austria $u Karl Landsteiner University of Health Sciences, Krems, Austria $u Department of Urology, Medical University of Vienna, Vienna, Austria
700    1_
$a Shariat, Shahrokh F $u Department of Urology, Medical University of Vienna, Vienna, Austria $u Department of Urology, University of Texas Southwestern Medical Center, Dallas, USA $u Division of Urology, Department of Special Surgery, The University of Jordan, Amman, Jordan $u Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic $u Department of Urology, Weill Cornell Medical College, New York, USA $u Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria
700    1_
$a Baltzer, Pascal A T $u Department of Biomedical Imaging and Image-Guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Vienna, Austria
700    1_
$a Clauser, Paola $u Department of Biomedical Imaging and Image-Guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Vienna, Austria
700    1_
$a Hartenbach, Markus $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
700    1_
$a Kenner, Lukas $u Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria $u Department of Pathology, Medical University of Vienna, Vienna, Austria $u Center for Biomarker Research in Medicine, Graz, Austria $u Unit for Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, Vienna, Austria
700    1_
$a Hacker, Marcus $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria
700    1_
$a Haug, Alexander R $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria $u Christian Doppler Laboratory for Applied Metabolomics, Vienna, Austria
700    1_
$a Rasul, Sazan $u Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria. sazan.rasul@meduniwien.ac.at $1 https://orcid.org/0000000328983232
773    0_
$w MED00181719 $t Insights into imaging $x 1869-4101 $g Roč. 15, č. 1 (2024), s. 299
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39666257 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250117 $b ABA008
991    __
$a 20250123101955 $b ABA008
999    __
$a ok $b bmc $g 2254429 $s 1237959
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 15 $c 1 $d 299 $e 20241212 $i 1869-4101 $m Insights into imaging $n Insights Imaging $x MED00181719
LZP    __
$a Pubmed-20250117

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...